Sign in

    Bill Chapman

    Research Analyst at Private Investor

    Bill Chapman's questions to PURE BIOSCIENCE (PURE) leadership

    Bill Chapman's questions to PURE BIOSCIENCE (PURE) leadership • Q1 2019

    Question

    Bill Chapman, a private investor, inquired about the anticipated timeline for seeking approval for PURE Control in raw meats and asked for clarification on the completion date for poultry testing.

    Answer

    CEO Henry Lambert explained that the company's current focus is on optimizing and commercializing PURE Control for poultry parts before expanding to other meats like beef and pork. He prioritized poultry due to its higher incidence of foodborne illness compared to other meats. Lambert confirmed the company's best estimate for completing poultry testing is mid-calendar 2019.

    Ask Fintool Equity Research AI